Literature DB >> 5645863

Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera.

C C Carpenter, R B Sack, J C Feeley, R W Steenberg.   

Abstract

The site and characteristics of gastrointestinal electrolyte loss were investigated in eight dogs with experimental cholera induced by orogastric administration of 6-hr broth cultures of Vibrio cholerae, strain Ogawa 395. In these animals, all electrolyte losses originated in the small bowel, predominantly from the jejunum and ileum. The bicarbonate concentration of the small bowel fluid showed a progressive increase from duodenum, where it was less than that of plasma, to the terminal ileum, where it was significantly greater than that of simultaneously obtained plasma. Studies of the responses of chronic Thiry-Vella jejunal loops (five dogs) and chronic Thiry-Vella ileal loops (five dogs) to intraluminal challenge by cholera exotoxin demonstrated that all loops exhibited isotonic electrolyte loss for a 14-18 hr period after challenge. The bicarbonate concentration of fluid produced by exotoxin-challenged jejunal loops was not significantly different from that of plasma, whereas the ileal loops produced fluid with a bicarbonate concentration approximately three times that of plasma. The effect of intraluminal glucose on the response of canine gut to cholera exotoxin was investigated by perfusion studies in 12 dogs with chronic Thiry-Vella fistulae. Intraluminal glucose significantly enhanced isotonic fluid absorption in both jejunal and ileal loops. The net effects of glucose on isotonic fluid absorption were equal before and after intraluminal administration of crude cholera exotoxin. These data suggest that cholera exotoxin causes gut electrolyte loss by a mechanism independent of that by which glucose enhances sodium absorption.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645863      PMCID: PMC297273          DOI: 10.1172/JCI105810

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  The exchange of lipids between plasma and lymph of animals.

Authors:  G C COURTICE; B MORRIS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1955-04

2.  Water and electrolyte studies in cholera.

Authors:  R H WATTEN; F M MORGAN; B VANIKIATI; R A PHILLIPS
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  The nature of the gastrointestinal lesion in asiatic cholera and its relation to pathogenesis: a biopsy study.

Authors:  E F GANGAROSA; W R BEISEL; C BENYAJATI; H SPRINZ; P PIYARATN
Journal:  Am J Trop Med Hyg       Date:  1960-03       Impact factor: 2.345

4.  The absorption of water and of some small solute molecules from the isolated small intestine of the rat.

Authors:  R B FISHER
Journal:  J Physiol       Date:  1955-12-29       Impact factor: 5.182

5.  Small intestinal absorption of steroids.

Authors:  H P SCHEDL; J A CLIFTON
Journal:  Gastroenterology       Date:  1961-11       Impact factor: 22.682

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Experimental cholera. A canine model.

Authors:  R B Sack; C C Carpenter; R W Steenburg; N F Pierce
Journal:  Lancet       Date:  1966-07-23       Impact factor: 79.321

8.  Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

Authors:  R A Finkelstein; P Atthasampunna; M Chulasamaya; P Charunmethee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

9.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

10.  Cholera in the perspective of 1966.

Authors:  R A Phillips
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

View more
  51 in total

1.  Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors.

Authors:  Qais Al-Awqati
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Effects of cholera toxin on cochlear endolymph production: model for endolymphatic hydrops.

Authors:  A M Feldman; S W Brusilow
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

3.  Effect of Klebsiella pneumoniae enterotoxin on intestinal transport in the rat.

Authors:  F A Klipstein; I R Horowitz; R F Engert; E A Schnenk
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

4.  Production of Biologically Active Substances by Two Strains of Vibrio cholerae.

Authors:  H Kusama; J P Craig
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

5.  Prevention and reversal of cholera enterotoxin-induced intestinal secretion by methylprednisolone induction of Na+-K+-ATPase.

Authors:  A N Charney; M Donowitz
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

6.  A case of cholera in Kingston, Ont.

Authors:  R Bourdages; I T Beck
Journal:  Can Med Assoc J       Date:  1976-09-04       Impact factor: 8.262

7.  Mechanism of production of intestinal secretion by elevated venous pressure.

Authors:  M E Yablonski; N Lifson
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

8.  Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial.

Authors:  N H Alam; H Ashraf; W A Khan; M M Karim; G J Fuchs
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Effects of long chain fatty acids on solute absorption: perfusion studies in the human jejunum.

Authors:  H V Ammon; P J Thomas; S F Phillips
Journal:  Gut       Date:  1977-10       Impact factor: 23.059

10.  Ultracytochemistry of cholera-toxin binding sites in ciliary processes.

Authors:  H Mishima; M Sears; L Bausher; D Gregory
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.